4//SEC Filing
Nelson Jennifer Ann 4
Accession 0000950170-24-131188
CIK 0001850838other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 6:31 PM ET
Size
5.5 KB
Accession
0000950170-24-131188
Insider Transaction Report
Form 4
Nelson Jennifer Ann
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-11-22+110,000→ 110,000 totalExercise: $0.79Exp: 2034-11-21→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable with respect to 25% of the underlying shares on November 15, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on November 15, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
Documents
Issuer
Omega Therapeutics, Inc.
CIK 0001850838
Entity typeother
Related Parties
1- filerCIK 0002046425
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 6:31 PM ET
- Size
- 5.5 KB